| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699748 | Clinical Oncology | 2006 | 9 Pages |
Abstract
This regimen has shown what might be considered high rates of grade 3 and 4 toxicity for an adjuvant treatment, although the delivered DI was acceptable. Caution is urged in the treatment of elderly female patients who have statistically higher rates of grade 3 and 4 toxicity and lower DI.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
V.S. Ramani, S.W. Gollins, H. Wong,